Showing results (1271-1280 of 1,518) with videos related to
Sort By:
Pageof 152
Psychopathology|December 7, 2007
Obsessive-compulsive disorder and posttraumatic stress disorderHans Joergen Grabe, Stephan Ruhrmann, Carsten Spitzer, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 14, 2026
AdvanTIG-302: Phase 3 Study of Ociperlimab (Anti-TIGIT) + Tislelizumab (Anti-PD-1) Versus Pembrolizumab in Untreated, Locally Advanced, Unresectable, or Metastatic Non-Small Cell Lung Cancer With PD-L1 ≥50Mark A Socinski, Martin Reck, Luis Paz-Ares, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2012
Safety, resource use, and quality of life in paramount: a phase III study of maintenance pemetrexed versus placebo after induction pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancerCesare Gridelli, Filippo de Marinis, Jean-Louis Pujol, et al.Dermatology and Therapy|May 3, 2024
Lebrikizumab Provides Rapid Clinical Responses Across All Eczema Area and Severity Index Body Regions and Clinical Signs in Adolescents and Adults with Moderate-to-Severe Atopic DermatitisEric L Simpson, Marjolein de Bruin-Weller, H Chih-Ho Hong, et al.Journal of Medicinal Chemistry|October 18, 2011
Novel N-linked aminopiperidine inhibitors of bacterial topoisomerase type II: broad-spectrum antibacterial agents with reduced hERG activityFolkert Reck, Richard Alm, Patrick Brassil, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2012
Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT studyM Kreuter, J Vansteenkiste, J R Fischer, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 28, 2022
Brief Report: Exploratory Analysis of Maintenance Therapy in Patients With Extensive-Stage SCLC Treated First Line With Atezolizumab Plus Carboplatin and EtoposideMartin Reck, Tony S K Mok, Aaron Mansfield, et al.ACS Applied Materials & Interfaces|July 16, 2024
High-Power Impulse Magnetron Sputter Deposition of Ag on Self-Assembled Au Nanoparticle Arrays at Low-Temperature Dewetting ConditionsTianfu Guan, Suzhe Liang, Yicui Kang, et al.The Lancet. Oncology|November 14, 2017
Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trialJulie R Brahmer, Delvys Rodríguez-Abreu, Andrew G Robinson, et al.Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
Treatment outcomes by histology in REVEL: A randomized phase III trial of Ramucirumab plus docetaxel for advanced non-small cell lung cancerLuis G Paz-Ares, Maurice Pérol, Tudor-Eliade Ciuleanu, et al.Pageof 152